FILTER

FILTERED INTERVIEW RESULTS

Mining
Ghana
MACIG

Georgette Barnes

PRESIDENT, WOMEN IN MINING
WIM Ghana is looking for ways make careers in mining more attractive to women.
Mining
Ghana
MACIG

Bashir Amed

VICE PRESIDENT OF PRODUCTION & DEVELOPMENT, ASANTE GOLD
Asante Gold discusses how the SMD technique will make its Kubi gold project more cost-efficient.
Mining
Ghana
MACIG

Serigne Ndanck Mbaye

CEO, DHL GHANA
DHL Ghana is part of DHL group, which is the global leader in logistics.
Mining
Mozambique
MACIG

Welington Soares

CEO, NORTHERN DEVELOPMENT CORRIDOR (CDN)
The Northern Development Corridor (CDN) was a Mozambique government infrastructure that became a private concession, with its largest stakeholders being Vale and Mitsui.
Mining
South Africa
MACIG

Leon Krüger

MANAGER HYDROMETALLURGY, MINTEK
Mintek is in the process of restructuring towards a model focused on introducing more cutting-edge technology and innovation.
Mining
South Africa
MACIG

George Olivier & Manie Kriel

DIRECTOR & CEO, VBKOM
Mining engineering consultancy VBKOM anticipates an era of growth as the mining cycle picks up.
Mining
South Africa
MACIG

Ossie Carstens

CEO & PROGRAMME MANAGER, MEMSA
MEMSA advocates for a stronger local manufacturing sector in South Africa.
Mining
South Africa
MACIG

Alistair Macfarlane

CO-DIRECTOR, MANDELA MINING PRECINCT
Mandela Mining Precinct is looking to help modernize the South African mining industry.
Mining
DRC
MACIG

Stephane Goupil

DRC COUNTRY MANAGER, EPIROC
Epiroc discusses its country operations in the high-risk, high-reward context of the DRC mining industry.
Mining
South Africa
MACIG

Adriano Gilli & Marco Deana

COMMERCIAL / BUSINESS DEVELOPMENT MANAGER FOR AFRICA & CORPORATE ROCKFALL SECTOR/TECHNICAL MANAGER, MACCAFERRI GROUP
Maccaferri Group highlights trends impacting Africa's mining engineering sector.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL